310 related articles for article (PubMed ID: 27668537)
21. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
[TBL] [Abstract][Full Text] [Related]
22. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog
Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H
Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504
[TBL] [Abstract][Full Text] [Related]
23. Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells.
Wang S; Mou Z; Ma Y; Li J; Li J; Ji X; Wu K; Li L; Lu W; Zhou T
Biochem Pharmacol; 2015 May; 95(2):98-109. PubMed ID: 25824241
[TBL] [Abstract][Full Text] [Related]
24. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
[TBL] [Abstract][Full Text] [Related]
25. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44
Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M; Zargar Balajam N
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28370734
[TBL] [Abstract][Full Text] [Related]
28. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
[TBL] [Abstract][Full Text] [Related]
29. [Effects of Survivin-T34A mutant on breast cancer cell in vitro and in vivo].
Deng X; Song H; Ren M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):648-51. PubMed ID: 25219251
[TBL] [Abstract][Full Text] [Related]
30. Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation.
Syahrani RA; Yunita E; Wanandi SI
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2631-2637. PubMed ID: 32986362
[TBL] [Abstract][Full Text] [Related]
31. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
32. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
[TBL] [Abstract][Full Text] [Related]
33. 3-O-methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells.
Buommino E; Tirino V; De Filippis A; Silvestri F; Nicoletti R; Ciavatta ML; Pirozzi G; Tufano MA
Cell Prolif; 2011 Oct; 44(5):401-9. PubMed ID: 21951283
[TBL] [Abstract][Full Text] [Related]
34. Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
Das T; Nair RR; Green R; Padhee S; Howell M; Banerjee J; Mohapatra SS; Mohapatra S
Anticancer Res; 2017 Apr; 37(4):1655-1663. PubMed ID: 28373426
[TBL] [Abstract][Full Text] [Related]
35. Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis.
Hermawan A; Khumaira A; Ikawati M; Putri H; Jenie RI; Angraini SM; Muflikhasari HA
Comput Biol Chem; 2021 Feb; 90():107427. PubMed ID: 33360419
[TBL] [Abstract][Full Text] [Related]
36. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
[TBL] [Abstract][Full Text] [Related]
37. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
38. Lx2-32c inhibits the formation of mammosphere from MDA-MB-231 cells and induces apoptosis involving in down-regulating FoxM1.
Cai P; Xiao Z; Pan T; Wen X; Cao J; Ouyang B
Biomed Pharmacother; 2018 Jun; 102():1176-1181. PubMed ID: 29710535
[TBL] [Abstract][Full Text] [Related]
39. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
40. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
